Table 2.
FY | HLOT | Non-HLOT | Discontinued | Death | Total |
---|---|---|---|---|---|
2014 | 35,921 (72%) | 8935 (18%) | 3128 (6.3%) | 1724 (3.5%) | 49,708 |
2015 | 31,479 (72%) | 7967 (18%) | 2992 (6.8%) | 1484 (3.4%) | 43,922 |
2016 | 26,604 (69%) | 7693 (20%) | 2786 (7.3%) | 1225 (3.2%) | 38,308 |
2017 | 20,051 (64%) | 7638 (25%) | 2460 (7.9%) | 1026 (3.3%) | 31,175 |
2018 | 14,732 (64%) | 5747 (25%) | 1798 (7.8%) | 722 (3.1%) | 22,999 |
Markov chain models were calculated for fiscal years (FY) 2014 through 2018. The proportion of patients who received high-dose, long-term opioid therapy (HLOT) at the beginning of the FY and stayed in HLOT, transitioned to non-HLOT, discontinued, or died were calculated for each FY and presented in the table above